The fusion of NAIP and OCLN was described previously by Micci et al., in endometrial stroma sarcoma [64] and by Iwakawa et al., in lung cancer cells [65]; however, this study is the first to report this gene fusion in prostate cancer. This evidence concerns the gene OCLN and prostate cancer.